| Verapamil, Trandolapril |
№ ІІ-6342/01.12.2009 |
TARKA, Modified release tablet, 240 mg/ 4 mg, mg, Pack: 28 |
Abbott Laboratories GmbH, Германия |
AbbVie Deutschland GmbH & Co KG, Германия |
28.07 |
5.61 |
33.68 |
6% |
1.68 |
29.75 |
5.95 |
35.7 |
18% |
5.05 |
34.8 |
6.96 |
41.76 |
корекц. КЦ-2840/06.10.2011 ; промяна на обстоятелства НСР-4194/30.07.2014( в сила от 13.08.2014) |
КЦ-2480/20.06.2011 |
22.08.2011 |
22.08.2011 |
Неактивен |
3889 |
| Verapamil, Trandolapril |
№ ІІ-6341/01.12.2009 |
TARKA, Modified release tablet, 240 mg/ 2 mg, mg, Pack: 28 |
Abbott GmbH & Co KG, Германия |
Abbott GmbH & Co KG, Германия |
19.87 |
3.97 |
23.84 |
6% |
1.19 |
21.06 |
4.21 |
25.27 |
18% |
3.58 |
24.64 |
4.93 |
29.57 |
|
КЦ-2139/19.04.2011 |
25.05.2011 |
25.05.2011 |
Неактивен |
2552 |
| Verapamil, Trandolapril |
II-15587/29.12.2006 |
TARKA, Modified release tablet, 180 mg/ 2 mg, mg, Pack: 28 |
Abbott GmbH & Co KG, Германия |
Abbott GmbH&CoKG, Knollstrasse 50, Ludwigshafen / Германия |
16.33 |
3.27 |
19.6 |
8% |
1.31 |
17.64 |
3.53 |
21.17 |
20% |
3.27 |
20.91 |
4.18 |
25.09 |
|
КЦ-453/21.01.2009 |
12.02.2009 |
12.02.2009 |
Неактивен |
3888 |
| Nilotinib |
EU/1/07/422/001 |
Tasigna, Capsule, hard, 200, mg, Pack: 28 |
Novartis Europharm Limited, Обединено Кралство |
Novartis PHarma GmbH Germany |
1452.32 |
290.46 |
1742.78 |
4% |
10 |
1462.32 |
292.46 |
1754.78 |
16% |
25 |
1487.32 |
297.46 |
1784.78 |
|
КЦРР-2816/20.03.2013; НСР-9791/14.07.2016 |
02.08.2016 |
02.08.2016 |
Активен |
1828 |
| Nilotinib |
EU/1/07/422/001 |
Tasigna, Capsule, hard, 200, mg, Pack: 28 |
Novartis Europharm Limited, Обединено Кралство |
Novartis PHarma GmbH Germany |
1744.17 |
348.83 |
2093 |
4% |
10 |
1754.17 |
350.83 |
2105 |
16% |
25 |
1779.17 |
355.83 |
2135 |
|
КЦРР-2816/20.03.2013 |
23.04.2013 |
23.04.2013 |
Неактивен |
1828 |
| Nilotinib |
EU/1/07/422/005 |
Tasigna, Capsule, hard, 150, mg, Pack: 28 |
Novartis Europharm Limited, Обединено Кралство |
Novartis PHarma GmbH Germany |
1089.24 |
217.85 |
1307.09 |
4% |
10 |
1099.24 |
219.85 |
1319.09 |
16% |
25 |
1124.24 |
224.85 |
1349.09 |
|
КЦРР-2815/20.03.2013; НСР-9792/14.07.2016 |
02.08.2016 |
02.08.2016 |
Активен |
1827 |
| Nilotinib |
EU/1/07/422/005 |
Tasigna, Capsule, hard, 150, mg, Pack: 28 |
Novartis Europharm Limited, Обединено Кралство |
Novartis PHarma GmbH Germany |
1278.13 |
255.63 |
1533.76 |
4% |
10 |
1288.13 |
257.63 |
1545.76 |
16% |
25 |
1313.13 |
262.63 |
1575.76 |
|
КЦРР-2815/20.03.2013 |
23.04.2013 |
23.04.2013 |
Неактивен |
1827 |
| Nilotinib |
EU/1/07/422/005 |
Tasigna, Capsule, hard, 150, mg, Pack: 28 |
Novartis Europharm Limited, Обединено Кралство |
Novartis PHarma GmbH Germany |
1278.17 |
255.63 |
1533.8 |
4% |
10 |
1288.17 |
257.63 |
1545.8 |
16% |
25 |
1313.17 |
262.63 |
1575.8 |
|
КЦ-2386/17.06.2011 |
01.07.2011 |
01.07.2011 |
Неактивен |
1827 |
| Nilotinib |
EU/1/07/422/001 |
Tasigna, Capsule, hard, 200, mg, Pack: 28 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Germany |
1983.64 |
396.73 |
2380.37 |
4% |
10 |
1993.64 |
398.73 |
2392.37 |
16% |
25 |
2018.64 |
403.73 |
2422.37 |
|
КЦ-297/14.11.2008 |
01.12.2008 |
01.12.2008 |
Неактивен |
1828 |
| Levofloxacin |
20020444 |
TAVANIC, Solution for infusion, 5 mg/ml - 100 ml, mg, Pack: 1 |
Санофи-Авентис България ЕООД, България |
Sanofi-Aventis deutschland GmbH, Германия |
25.56 |
5.11 |
30.67 |
6% |
1.53 |
27.09 |
5.42 |
32.51 |
18% |
4.6 |
31.69 |
6.34 |
38.03 |
|
НСР-7465/12.11.2015 |
27.11.2015 |
27.11.2015 |
Активен |
3147 |
| Levofloxacin |
20020444 |
TAVANIC, Solution for infusion, 5 mg/ml - 100 ml, mg, Pack: 1 |
Санофи-Авентис България ЕООД, България |
Sanofi-Aventis deutschland GmbH, Германия |
27.77 |
5.55 |
33.32 |
6% |
1.67 |
29.44 |
5.89 |
35.33 |
18% |
5 |
34.44 |
6.89 |
41.33 |
|
НСР-4454/15.08.2014 |
01.09.2014 |
01.09.2014 |
Неактивен |
3147 |
| Levofloxacin |
3720/09,12,2008 |
TAVANIC, Solution for infusion, 5 mg/ml - 100 ml, mg, Pack: 1 |
Санофи-Авентис България ЕООД, България |
Sanofi-Aventis Deutschland GmbH |
30.92 |
6.18 |
37.1 |
4% |
1.24 |
32.16 |
6.43 |
38.59 |
16% |
4.95 |
37.11 |
7.42 |
44.53 |
|
НСР-1608/01.11.2013 |
04.12.2013 |
04.12.2013 |
Неактивен |
3147 |
| Levofloxacin |
3720/09,12,2008 |
TAVANIC, Solution for infusion, 5 mg/ml - 100 ml, mg, Pack: 1 |
Санофи-Авентис България ЕООД, България |
Sanofi-Aventis Deutschland GmbH |
44.48 |
8.9 |
53.38 |
4% |
1.78 |
46.26 |
9.25 |
55.51 |
16% |
7.12 |
53.38 |
10.68 |
64.06 |
КЦ-920/26.05.2009 промяна на обстоятелства |
КЦ-470/29.01.2009 |
12.02.2009 |
12.02.2009 |
Неактивен |
3147 |
| Docetaxel |
EU/1/95/002/004 |
TAXOTERE, Concentrate for solution for infusion, 80 mg/4 ml, mg, Pack: 1 |
Aventis Pharma S.A., Франция |
Aventis Pharma Dagenham Rainham Road South Dagenham, Essex RM10 7XS,Великобритания; Sanofi-Aventis Deutschland GmbH Frankfurt am Main, Германия; Sanofi-Aventis Zrt., Унгария |
195.35 |
39.07 |
234.42 |
4% |
7.81 |
203.16 |
40.63 |
243.79 |
16% |
25 |
228.16 |
45.63 |
273.79 |
промяна обстоятелства-НСР-9448/01.06.2016 |
НСР-8047/12.02.2016.; НСР-9571/17.06.2016 |
27.02.2016 |
02.08.2016 |
Заличен |
3276 |
| Docetaxel |
EU/1/95/002/004 |
TAXOTERE, Concentrate for solution for infusion, 80 mg/4 ml, mg, Pack: 1 |
Aventis Pharma S.A., Франция |
Aventis Pharma Dagenham Rainham Road South Dagenham, Essex RM10 7XS,Великобритания; Sanofi-Aventis Deutschland GmbH Frankfurt am Main, Германия; Sanofi-Aventis Zrt., Унгария |
195.35 |
39.07 |
234.42 |
4% |
7.81 |
203.16 |
40.63 |
243.79 |
16% |
25 |
228.16 |
45.63 |
273.79 |
промяна обстоятелства-НСР-9448/01.06.2016 |
НСР-8047/12.02.2016. |
27.02.2016 |
27.02.2016 |
Неактивен |
3276 |
| Docetaxel |
EU/1/95/002/003 |
TAXOTERE, Concentrate for solution for infusion, 20 mg/1 ml, mg, Pack: 1 |
Aventis Pharma S.A., Франция |
Aventis Pharma Dagenham Rainham Road South Dagenham, Essex RM10 7XS,Великобритания; Sanofi-Aventis Deutschland GmbH Frankfurt am Main, Германия; Sanofi-Aventis Zrt., Унгария |
48.86 |
9.77 |
58.63 |
4% |
1.95 |
50.81 |
10.16 |
60.97 |
16% |
7.82 |
58.63 |
11.73 |
70.36 |
промяна обстоятелства НСР-9463/01.06.2016 |
НСР-8047/12.02.2016.; НСР-9570/17.06.2016 |
27.02.2016 |
02.08.2016 |
Заличен |
3275 |
| Docetaxel |
EU/1/95/002/003 |
TAXOTERE, Concentrate for solution for infusion, 20 mg/1 ml, mg, Pack: 1 |
Aventis Pharma S.A., Франция |
Aventis Pharma Dagenham Rainham Road South Dagenham, Essex RM10 7XS,Великобритания; Sanofi-Aventis Deutschland GmbH Frankfurt am Main, Германия; Sanofi-Aventis Zrt., Унгария |
48.86 |
9.77 |
58.63 |
4% |
1.95 |
50.81 |
10.16 |
60.97 |
16% |
7.82 |
58.63 |
11.73 |
70.36 |
промяна обстоятелства НСР-9463/01.06.2016 |
НСР-8047/12.02.2016. |
27.02.2016 |
27.02.2016 |
Неактивен |
3275 |
| Docetaxel |
EU/1/95/002/004 |
TAXOTERE, Concentrate for solution for infusion, 80 mg/4 ml, mg, Pack: 1 |
Aventis Pharma S.A., Франция |
Aventis Pharma Dagenham Rainham Road South Dagenham, Essex RM10 7XS,Великобритания; Sanofi-Aventis Deutschland GmbH Frankfurt am Main, Германия |
195.35 |
39.07 |
234.42 |
4% |
7.81 |
203.16 |
40.63 |
243.79 |
16% |
25 |
228.16 |
45.63 |
273.79 |
|
НСР-8047/12.02.2016. |
27.02.2016 |
27.02.2016 |
Неактивен |
3276 |
| Docetaxel |
EU/1/95/002/003 |
TAXOTERE, Concentrate for solution for infusion, 20 mg/1 ml, mg, Pack: 1 |
Aventis Pharma S.A., Франция |
Aventis Pharma Dagenham Rainham Road South Dagenham, Essex RM10 7XS,Великобритания; Sanofi-Aventis Deutschland GmbH Frankfurt am Main, Германия |
48.86 |
9.77 |
58.63 |
4% |
1.95 |
50.81 |
10.16 |
60.97 |
16% |
7.82 |
58.63 |
11.73 |
70.36 |
|
НСР-8047/12.02.2016. |
27.02.2016 |
27.02.2016 |
Неактивен |
3275 |
| Docetaxel |
EU/1/95/002/004 |
TAXOTERE, Concentrate for solution for infusion, 80 mg/4 ml, mg, Pack: 1 |
Aventis Pharma S.A., Франция |
Aventis Pharma Dagenham Rainham Road South Dagenham, Essex RM10 7XS,Великобритания; Sanofi-Aventis Deutschland GmbH Frankfurt am Main, Германия |
294.25 |
58.85 |
353.1 |
4% |
10 |
304.25 |
60.85 |
365.1 |
16% |
25 |
329.25 |
65.85 |
395.1 |
|
НСР-4896/22.10.2014 |
06.11.2014 |
06.11.2014 |
Неактивен |
3276 |
| Docetaxel |
EU/1/95/002/003 |
TAXOTERE, Concentrate for solution for infusion, 20 mg/1 ml, mg, Pack: 1 |
Aventis Pharma S.A., Франция |
Aventis Pharma Dagenham Rainham Road South Dagenham, Essex RM10 7XS,Великобритания; Sanofi-Aventis Deutschland GmbH Frankfurt am Main, Германия |
73.4 |
14.68 |
88.08 |
4% |
2.94 |
76.34 |
15.27 |
91.61 |
16% |
11.74 |
88.08 |
17.62 |
105.7 |
|
НСР-4897/22.10.2014 |
06.11.2014 |
06.11.2014 |
Неактивен |
3275 |
| Docetaxel |
EU/1/95/002/003 |
TAXOTERE, Concentrate and solvent for solution for infusion, 20 mg/0.5 ml, mg, Pack: 1 |
Aventis Pharma S.A., Франция |
Aventis Pharma Dagenham Rainham Road South Dagenham, Essex RM10 7XS,Великобритания |
95.09 |
19.02 |
114.11 |
4% |
3.8 |
98.89 |
19.78 |
118.67 |
16% |
15.21 |
114.1 |
22.82 |
136.92 |
Цената е заличена с решение НСР-1360/07.10.2013 |
НСР-969/12.08.2013 |
29.08.2013 |
29.08.2013 |
Заличен |
2044 |
| Docetaxel |
EU/1/95/002/004 |
TAXOTERE, Concentrate and solvent for solution for infusion, 80 mg/2 ml, mg, Pack: 1 |
Aventis Pharma S.A., Франция |
Aventis Pharma Dagenham Rainham Road South Dagenham, Essex RM10 7XS,Великобритания |
465.33 |
93.07 |
558.4 |
4% |
10 |
475.33 |
95.07 |
570.4 |
16% |
25 |
500.33 |
100.07 |
600.4 |
Цената е заличена с решение НСР-1359/07.10.2013 |
НСР-968/12.08.2013 |
29.08.2013 |
29.08.2013 |
Заличен |
2043 |
| Docetaxel |
EU/1/95/002/003 |
TAXOTERE, Concentrate for solution for infusion, 20 mg/1 ml, mg, Pack: 1 |
Aventis Pharma S.A., Франция |
Aventis Pharma Dagenham Rainham Road South Dagenham, Essex RM10 7XS,Великобритания; Sanofi-Aventis Deutschland GmbH Frankfurt am Main, Германия |
86 |
17.2 |
103.2 |
4% |
3.44 |
89.44 |
17.89 |
107.33 |
16% |
13.76 |
103.2 |
20.64 |
123.84 |
промяна на обстоятелства НСР-4012/30.06.2014 |
НСР-970/12.08.2013 |
29.08.2013 |
29.08.2013 |
Неактивен |
3275 |
| Docetaxel |
EU/1/95/002/004 |
TAXOTERE, Concentrate for solution for infusion, 80 mg/4 ml, mg, Pack: 1 |
Aventis Pharma S.A., Франция |
Aventis Pharma Dagenham Rainham Road South Dagenham, Essex RM10 7XS,Великобритания; Sanofi-Aventis Deutschland GmbH Frankfurt am Main, Германия |
343.99 |
68.8 |
412.79 |
4% |
10 |
353.99 |
70.8 |
424.79 |
16% |
25 |
378.99 |
75.8 |
454.79 |
промяна на обстоятелства НСР-4012/30.06.2014 |
НСР-971/12.08.2013 |
29.08.2013 |
29.08.2013 |
Неактивен |
3276 |